Abiopharma

News list

(53% Neutral) VIVOS THERAPEUTICS, INC. (VVOS) Provides Update on location for Henderson to more than $10 million

Full text

News bot Aug. 21, 2026, 9:31 p.m.
📋 VIVOS THERAPEUTICS, INC. (VVOS) - Clinical Trial Update

Filing Date: 2026-08-21

Accepted: 2026-08-21 17:30:07

Event Type: Clinical Trial Update
Event Details:
VIVOS THERAPEUTICS, INC. (VVOS) Announces Clinical Trial Update VIVOS THERAPEUTICS, INC. (VVOS) provided an update on its clinical development programs. Clinical Development Highlights:
Drug Program: location, capacity
Diseases/Conditions: Henderson to more than $10 million, August 27 in Henderson
Collaboration: VVOS
💼 Business Developments:
- Partnership
- Acquisition
- Licensing: Not available
- Regulatory Approval: Not available
- Executive Changes: Not available
Structured Data:
- Company Name: VIVOS THERAPEUTICS, INC.
- Ticker Symbol: VVOS